Bacteremia caused by coagulase-negative staphylococci: Incidence, frequency of teicoplanin resistance and molecular epidemiology;Bactériémies liées aux staphylocoques à coagulase négative: Incidence, niveau de résistance à la teicoplanine et épidémiologie moléculaire

Pathologie Biologie

Volumn 50, Issue 9, 2002, Pages 552-559

  Bertrand, X ^a   Lallemand, S ^a   Thouverez, M ^a   Boisson, K ^a   Talon, D ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Bacteremia; Coagulase negative staphylococci; Decreased susceptibility to teicoplanin; Molecular epidemiology

Indexed keywords

FUSIDIC ACID; GENTAMICIN; GLYCOPEPTIDE; OFLOXACIN; OXACILLIN; RIFAMPICIN; TEICOPLANIN; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENOTYPE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; PHYLOGENETIC TREE; PREVALENCE; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; FEMALE; FRANCE; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TEICOPLANIN;

EID: 17344380005     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(02)00347-4     Document Type: Conference Paper

References (21)

1. Pfaller MA, Herwaldt LA. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1988;1:281-99.
2. Bussy-Malgrange V, Bajolet-Laudinat O, Gerdeaux M, Laplatte G, Mulin B, Reveil JC, Gayet S, et Réseau CCLIN Est. Epidémiologie des bactériémies nosocomiales dans l'est de la France. Pathol Biol 1998;46:403-7.
3. Rupp ME, Archer GL. Coagulase-negative staphylococci: Pathogens associated with medical progress. Clin Infect Dis 1994;19:231-45.
4. Kloos WE, Bannerman TL. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 1994;7:117-40.
5. Martin MA, Pfaller MA, Wenzel RP. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med 1989;110:9-16.
6. Archer GL, Climo MW. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrobial Agents Chemother 1994;38: 2231-7.
7. Soussy CJ, Carret G, Cavallo JD, Chardon H, Chidiac C, Choutet P, et al. Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 2000-2001. Pathol Biol 2000;48:832-71.
8. Mainardi JL, Shlaes DM, Goering RV, Shlaes JH, Acar JF, Goldstein FW. Decreased teicoplanin susceptibility of methicillin resistant strains of Staphylococcus aureus. J Infect Dis 1995;171:1646-50.
9. Bertrand X, Thouverez M, Talon D. Antibiotic susceptibility and genotypic characterization of methicillin-resistant Staphylococcus aureus strains in eastern France. J Hosp Infect 2000;46:280-7.
10. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpretative chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
11. Natsch S, Hekster YA, Jong de R, Heerdink ER, Herings RM, van der Meer JW. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis 1998;17:20-4.
12. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstreal infections in United States Hospitals: A three-year analysis. Clin Infect Dis 1999;29:239-44.
13. Gerberding J, Gaynes R, Horan T, Abshire J, Alonso-Echanove J, Edwards J. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999;27:520-32.
14. Del'Alamo L, Cereda RF, Tosin I, Miranda EA, Sader HF. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides. Diagnostic Microbiol Infect Dis 1999;34:185-91.
15. Cercenado E, Garcia-Leoni ME, Diaz MD, Sanchez-Carrillo C, Catalan P, De Quiros JC. Emergence of teicoplanin-resistant coagulase-negative staphylococci. J Clin Microbiol 1996;34: 1765-8.
16. Garrett DO, Jochimsen E, Murfitt B, Hill K, McAllister S, Nelson P, et al. The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis. Infect Control Hosp Epidemiol 1999;20:167-70.
17. Schlegel L, Saliba F, Mangeney N, Mathieu D. Pulsed field gel electrophoresis typing of coagulase-negative staphylococci with decreased susceptibility to teicoplanin isolated from an intensive care unit. J Hosp Infect 2001;49:62-8.
18. Biavasco F, Vignaroli C, Varaldo PE. Glycopeptide resistance in coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis 2000;19:403-17.
19. Sloos JH, van de Klundert JAM, Dijkshoorn L, van Boven CPA. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital. J Antimicrobial Chemother 1998;42:787-91.
20. Jansen B, Schumacher-Perdreau F, Pulverer G. Susceptibility of staphylococci and enterococci to glycopeptides: Comparison of three test methods. Zentralblatt für Bakteriologie 1995;282:402-8.
21. Miragaia M, Couto I, Pereira SFF, Kristinsson KG, Westh H, Jarløv JO, et al. Molecular Characterization of Methicillin- Resistant Staphylococcus epidermidis Clones: Evidence of Geographic Dissemination. J Clin Microbiol 2002;40:430-8.